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BY-NC-ND license (http://creativecoAbstract Background/aim: Major hepatectomies are widely used in curative-intent surgery
for perihilar cholangiocarcinoma, but morbidity rates are high. The aim of the study is to
explore potential predictors for clinically relevant complications after major hepatectomies
for perihilar cholangiocarcinoma.
Methods: Seventy patients were included. Univariate and multivariate analyses were per-
formed for risk factors of morbidities using the International Study Group of Liver Surgery def-
initions.
Results: Severe morbidity rate was 36.5%. Clinically relevant posthepatectomy liver failure,
bile leak, and hemorrhage rates were 24%, 22%, and 8.5%, respectively. A neutrophil-to-
lymphocyte ratio > 3.3 is an independent prognostic factor for severe complications (hazard
ratio Z 1.258; 95% confidence interval 1.008e1.570; p Z 0.042) while the number of blood
units > 3 is an independent prognostic factor for clinically relevant liver failure (hazard
ratio Z 1.254; 95% confidence interval 1.082e1.452; p Z 0.003). Biliary drainage and portal
vein resection were not statistically correlated with any postoperative complication (p 
0.101). Significantly higher bilirubinemia levels were observed in patients with postoperative
hemorrhage (p Z 0.023).
Conclusion: Clinically relevant morbidity rates after major hepatectomies for perihilar cholan-
giocarcinoma are high. Liver failure represents the main complication and is correlated witheneral Surgery and Liver Transplant, Fundeni Clinical Institute, Fundeni Street Number 258, 022328,
0@gmail.com, traian.dumitrascu76@gmail.com (I. Popescu).
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82 T. Dumitrascu et al.the number of transfused blood units. A patient with increased bilirubinemia appears to have a
high risk for postoperative hemorrhage. Biliary drainage and portal vein resection does not
appear to have a detrimental effect on morbidities. Neutrophil-to-lymphocyte ratio is a novel
independent predictor for severe morbidity after major hepatectomies for perihilar cholangio-
carcinoma and may contribute to better and informed decision-making.
Copyright ª 2015, Asian Surgical Association. Published by Elsevier Taiwan LLC. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Perihilar cholangiocarcinoma (PHC) is considered as a chol-
angiocarcinoma involving the hilar bile duct (i.e., bile duct
located between the right side of the umbilical portion of the
left portal vein and the left side of the origin of the posterior
portal vein).1 Major hepatectomies with extrahepatic bile
duct resection and loco-regional lymphadenectomy repre-
sent the standard approach for curative-intent surgery in the
largest part of patients with PHC and have been associated
with significant improvements for resectability and survival
rates.2e6 Nowadays, decreased mortality rates after major
hepatectomies were observed in referral centers,4e7 but for
patients with PHC mortality rates are significantly higher
compared with other pathologies8 and ranges from 1.4% to
12%.2e6,9,10 Major hepatectomies with zero mortality were
also reported.11 Conversely, morbidity rates after major
hepatectomies are still high,8,12 particularly in patients with
PHC because they are more likely to present added potential
risk factors such as obstructive jaundice with or without
cholangitis.10,12 Thus, morbidity rates after hepatectomies
for PHC ranges from 43% to 81%2e6,9,10,13 and the main
complications are represented by liver failure, hemorrhage,
and septic complications due to bile leak.2e6,8,10,13
In the literature, there is a broad spectrum of definitions
for major liver resections.8,9,11,13e16 Recently, it was sug-
gested that resection of four or more liver segments should
be considered the standard definition for major hepatec-
tomies.17 Furthermore, standard definitions and grading
systems were proposed in 2011 by the International Study
Group of Liver Surgery (ISGLS) for specific complications
such as posthepatectomy liver failure,18 posthepatectomy
hemorrhage,19 and bile leak.20
Up to now, there are only several studies investigating
potential risk factors for postoperative complications after
liver resection for PHC and the studies do not always include
patients with only major hepatectomies.5,6,10,11,21e25 Major
hepatectomies are differently defined, and the postoperative
complications are not standardized according to the ISGLS
definitions or Dindo-Clavien classification,6,8,11,13,21e25
except in very few studies.5,9,10,16 Thus, there are a lack of
data regarding potential predictors for clinically relevant
complications after major hepatectomies for PHC and a study
addressing this issue appears to be of interest.
The aim of the present study is to investigate potential
risk factors for clinically relevant postoperative complica-
tions after major hepatectomies for PHC in a relatively
large, single center experience, using the ISGLS definitions
for specific morbidities.2. Methods
2.1. Study population, inclusion criteria, and
primary endpoint
Seventy patients, recruited from 1996 to 2012 at our
Department of Surgery,were included. Inclusion criteriawere
as follows. (1) Final pathological diagnosis of PHC (i.e., hilar
cholangiocarcinomas or intrahepatic cholangiocarcinomas
invading the biliary convergence). Perihilar chol-
angiocarcinoma was considered according to the definition
provided by Ebata et al.1 (2) Major liver resections (defined as
 four resected liver segments), combined with extrahepatic
bile duct resection, and loco-regional lymphadenectomy. (3)
Estimated future liver remnant volume  30%.
The primary end point of the study was the identification
of risk factors for clinically relevant postoperative compli-
cations that might be potentially useful in clinical decision-
making for patients with PHC proposed for major
hepatectomies.
The data of the patients were retrospectively assessed
from a prospectively gathered electronic database and
included pre-, intra-, and postoperative data (available for
all patients). The study was approved by the Ethics Com-
mittee at our institution.
2.2. Preoperative characteristics of the patients
The median age was 59 years, with male gender predomi-
nance (40 patients, 57%). Cardiovascular comorbidities and
diabetes mellitus were observed in 19 patients (27%) and
five patients (7%), respectively.
Most of the patients presented with jaundice (59 pa-
tients, 84%), and 18 patients (26%) showed signs of chol-
angitis, due to the presence of the disease in eight patients
(11%) and related to biliary drainage in 10 patients (14%).
Preoperative biliary drainage was performed for 15 pa-
tients (21%): percutaneously (5 patients, 7%), endoscopically
(5 patients, 7%), or by previous surgery (5 patients, 7%). Only
eight patients (11%) were considered for preoperative biliary
drainage in our unit (indicated only in patients with chol-
angitis with impaired renal function); another five patients
(7%) had already received biliary drainage while previous
surgical exploration, and two patients (3%) were referred
from gastroenterologists with palliation of jaundice. No pa-
tient underwent preoperative portal vein embolization.
Preoperative median serum level of bilirubin was
10.5 mg/dL, aspartate-aminotransferase 123 U/L, alanil-
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inine 0.8 mg/dL, hemoglobin 12.3 g/dL, leukocytes 8750 mL,
lymphocytes 1600 mL, neutrophiles 5800 mL, neutrophil-to-
lymphocyte ratio 3.3, thrombocytes 323,000 mmc,
thrombocyte-to-lymphocyte ratio 183, and the CA 19-9
serum level was 375 UI/mL. Preoperative bioumoral param-
eters were assessed no more than 1 week prior to resection.
2.3. Operative characteristics of the patients
All patients underwent extrahepatic bile duct resection,
loco-regional lymphadenectomy, and one of the following
liver resections, as shown in Table 1.
The median tumor diameter was 3 cm (range,
0.5e10 cm). Portal vein resection was performed in 17
patients (24%) when invasion was suspected at preoperative
imaging or intraoperative exploration.
The median intraoperative blood loss was 800 mL, and 53
patients (76%) required per operative blood transfusions.
The median operating time was 300 minutes.
2.4. Assessments of postoperative complications
Postoperative complications were assessed with the Dindo-
Clavien classification26 and the ISGLS definitions and
severity grading for posthepatectomy liver failure,18 bile
leak,20 and hemorrhage.19 In patients with more than one
postoperative complication, the highest grade of severity
was considered. Severe complications were considered
Grade IIIeV Dindo-Clavien while clinically relevant com-
plications were defined as Grades B and C of the ISGLS
grading. Postoperative mortality was assessed at 90 days.
2.5. Statistical analysis
The data are expressed as n (%) and median. Univariate
analysis for potential risk factors utilized ManneWhitney U
test for continuous variables and Fisher’s exact test for
categorical variables. Multivariate analysis used a linear
logistic binary regression forward stepwise model to
analyze variables with p < 0.10 in univariate analysis, afterTable 1 Operative characteristics in 70 patients with
major hepatectomies for perihilar cholangiocarcinoma.
Surgical procedure No. of
patients (%)
EHBDRa þ left hemi-
hepatectomy þ caudate lobectomy
34 (49)
EHBDR þ right hemi-
hepatectomy þ caudate lobectomy
15 (21)
EHBDR þ right hemi-hepatectomy 12 (17)
EHBDR þ right
trisectionectomy þ caudate
lobectomy
6 (9)
EHBDR þ right trisectionectomy 3 (4)
a EHBDR e extrahepatic bile duct resection and loco-regional
lymphadenectomy (hepato-duodenal ligament, common he-
patic artery, posterior surface of the pancreatic head, right side
of the celiac trunk).elimination of intercorrelated factors. Pearson’s correla-
tion coefficient was used for continuous variables, while
Spearman’s rho correlation coefficient was used for cate-
gorical variables. A p value < 0.05 was considered statis-
tically significant. Statistical analysis was performed with
SPSS version 17.0 software (SPSS Inc., Chicago, IL, USA).3. Results3.1. Postoperative overall morbidity and mortality
Complications occurred in 44 patients (63%). According to
the Dindo-Clavien classification five patients were assessed
as Grade I (7%), 13 patients as Grade II (18%), nine patients
as Grade IIIa (13%), five patients as Grade IIIb (7%), four
patients as Grade IVa (5%), and one patient as Grade IVb
(1.5%). Median postoperative hospital stay was 16 days
(range, 1e65 days). Relaparotomy for complications was
necessary for 14 patients (20%).
Postoperative bile leak was observed in 20 patients
(29%): Grade A e four patients (6%), Grade B e 13 patients
(18%), and Grade C e three patients (4%). Postoperative
liver failure was observed in 20 patients (29%): Grade A e
three patients (4%), Grade B e 12 patients (17%), and Grade
C e five patients (7%). Postoperative hemorrhage was
observed in six patients (8.5%): Grade B e one patient
(1.5%), and Grade C e five patients (7%).
The 90-day mortality rate was 10% (7 patients) due to
postoperative liver failure (4 patients, 6%), sepsis with
multiorgan failure (2 patients, 3%) and hemorrhagic shock
(1 patient, 1.5%).
3.2. Predictors for severe postoperative
complications
Severe postoperative complications (i.e., Grades IIIeV
Dindo) were observed in 26 patients (36.5%). In univariate
analysis, the following factors were identified as predictors
for severe morbidity: creatinine serum level, lymphocyte
number, neutrophil-to lymphocyte ratio, CA 19-9 serum
level, blood and fresh frozen plasma unit number, and the
operative time (Tables 2 and 3). In multivariate analysis the
increased neutrophil-to-lymphocyte ratio (> 3.3) has been
identified as the single independent prognostic factor for
development of severe postoperative complications after
major hepatectomies for PHC (hazard ratio Z 1.258; 95%
confidence interval 1.008e1.570; p Z 0.042).
3.3. Predictors for clinically relevant
posthepatectomy bile leak using the ISGLS
definitions
Posthepatectomy bile leak rate in the present series was
29% with clinically relevant (Grades B and C) fistula rate of
22%. In univariate analysis, urea serum level and
neutrophil-to-lymphocyte ratio were identified as pre-
dictors for posthepatectomy clinically relevant bile leak
(Tables 2 and 3) but no independent risk factors were
identified in multivariate analysis.
Table 2 Univariate analysis for predictors of severe complications (i.e., Grade IIIeV Dindo), posthepatectomy clinically relevant (i.e., Grades B and C International Study
Group for Liver Surgery) bile leak, liver failure, and hemorrhage in 70 patients with major hepatectomies for perihilar chol-
angiocarcinoma (continuous variables).
Parameter* Severe complications Clinically relevant
Bile leak Liver failure Hemorrhage
No Ye p* No Yes p* No Yes p* No Yes p*
Age (y) 58 61 0.961 57 63 0.069 58 62 0.317 58 61 0.834
Bilirubin (mg/dL) 11 10.1 0.279 11 9 0.310 11 10 0.676 10 22 0.023
AST (U/L) 122 127 0.365 120 190 0.122 130 118 0.435 118 190 0.015
ALT (U/L) 170 156 1 150 240 0.064 183 147 0.127 153 210 0.151
Albumin (g/dL) 3.9 3.6 0.421 3.8 3.9 0.989 4 3.2 0.005 3.8 3.2 0.614
Urea (mg/dL) 37 40 0.493 35 40 0.027 37 40 0.725 35 45 0.028
Creatinine (mg/dL) 0.8 0.9 0.040 0.8 0.9 0.139 0.8 0.9 0.598 0.8 0.9 0.053
Hemoglobin (g/dL) 12.5 12 0.211 12.5 11.9 0.208 12.3 12.7 0.869 12.3 10.5 0.053
Leukocytes (mL) 8 600 9 000 0.772 8 800 8 600 0.939 8 600 9 200 0.661 8 600 9 200 0.197
Lymphocytes (mL) 1 700 1 600 0.047 1 600 1 400 0.055 1 700 1 400 0.035 1 600 1 400 0.436
Neutrophiles (mL) 5 600 6 500 0.101 5 800 5 800 0.160 5 600 6 500 0.110 5 600 7 300 0.136
Neutrophil-to-lymphocyte ratio 3.1 5.2 0.004 3.1 5.24 0.006 3.1 4.5 0.012 3.2 6.4 0.023
Thrombocytes (mL) 308 000 323 000 0.625 323 000 257 000 0.263 308 000 340 000 0.560 312 000 411 000 0.578
Thrombocyte-to-lymphocyte ratio 169.2 247.8 0.146 171 189.3 0.543 167.3 262.5 0.033 171.9 262.5 0.361
CA 19-9 (U/mL) 165 400 0.031 266 400 0.281 300 400 0.351 300 600 0.141
Tumor diameter (cm) 3 3 0.927 3 3 0.583 3 4 0.172 3 3 0.605
Intraoperative blood loss (mL) 700 1000 0.104 800 400 0.230 800 800 0.203 900 1 000 0.255
Blood units 2 5 0.010 3 2 0.687 3 6 0.001 3 8 0.011
Fresh frozen plasma units 2 4 0.022 2 2 0.887 2 6 0.002 2 8 0.028
Operative time (min) 280 360 0.008 300 270 0.774 300 320 0.190 300 270 0.599
Data are expressed as median.
* ManneWhitney U test.
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Table 3 Univariate analysis for predictors of severe complications (i.e., Grades IIIeV Dindo), posthepatectomy clinically
relevant (i.e., Grades B and C International Study Group for Liver Surgery) bile leak, liver failure, and hemorrhage in 70 patients
with major hepatectomies for perihilar cholangiocarcinoma (categorical variables).
Parametera Severe
complications
Clinically relevant
Bile leak Liver failure Hemorrhage
No Yes p* No Yes p* No Yes p* No Yes p*
Male gender 55 65 0.467 54 69 0.391 58 53 0.780 53 100% 0.033
Cardiovascular comorbidities 23 35 0.413 24 38 0.342 26% 29 1 28 17 1
Diabetes mellitus 11 0 0.148 7 6 1 9% 0 0.323 8 0 1
Jaundice 86 81 0.738 81 94 0.435 87 76 0.442 83 100 0.580
Cholangitis 18 38 0.100 22% 38 0.327 25 29 0.753 22 67 0.034
Preoperative biliary drainage 20 23 1 20 25 0.733 21 24 1 19 50 0.107
Right hemi-hepatectomy 32 50 0.216 39 38 1 34 53 0.251 38 50 0.669
Right trisectionectomy 14 12 1 15 6 0.673 8 29 0.032 14 0 1
Portal vein resection 20 31 0.567 26 19 0.744 19 41 0.101 23 33 0.627
Caudate lobectomy 82 73 0.554 80 75 0.733 85 59 0.038 78 83 1
Data are expressed as %.
* Fisher’s exact test.
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posthepatectomy liver failure using the ISGLS
definitions
Posthepatectomy liver failure rate in the present series was
29% and clinically relevant (Grades B and C) in 24% of the
patients. In univariate analysis, the following factors were
identified as risk factors for clinically relevant liver failure:
albumin serum level, lymphocyte number, neutrophil-to-
lymphocyte ratio, thrombocyte-to-lymphocyte ratio, blood
and fresh frozen plasma unit number, right trisectionec-
tomy, and caudate lobectomy (Tables 2 and 3). In multi-
variate analysis, the number of blood units (> 3) has been
identified as the single independent prognostic factor for
the development of clinically relevant liver failure after
hepatectomies for PHC (hazard ratio Z 1.254; 95% confi-
dence interval 1.082e1.452; p Z 0.003).
3.5. Predictors for clinically relevant
posthepatectomy hemorrhage using the ISGLS
definitions
Posthepatectomy hemorrhage rate in the present series
was 8.5%, all clinically relevant (Grades B and C). In uni-
variate analysis, the following factors were identified as
predictors for posthepatectomy hemorrhage: bilirubin
serum level, aspartate aminotransferase serum level, urea
serum level, neutrophil-to-lymphocyte ratio, blood and
fresh frozen plasma unit number, male gender, and pres-
ence of cholangitis (Tables 2 and 3). No independent risk
factors were identified in multivariate analysis.
4. Discussion
The concept of PHC has been demonstrated as valid5 but
the curative-intent surgery for these patients still remains
challenging, even in referral centers.5,10 In a recent mul-
ticentre European study (including only patients with majorhepatectomies for PHC), the overall morbidity rate was
68.6%, with severe complication rates of 27.6%, and mor-
tality rates of 10.7%.10 Similar results were observed in the
present series: overall morbidity rate of 63%, severe
complication rate of 38.5%, including the mortality rate of
10%. Thus, one might conclude that nowadays such complex
surgical procedures are still associated with increased rates
of postoperative complications.27 It was suggested as a
potential detrimental effect of the postoperative compli-
cations on long-term outcomes,9 but our previous studies
failed to sustain this finding after curative-intent surgery
for Klatskin tumors.28
The ISGLS grading system for posthepatectomy specific
complications is only retrospectively assessed and is not
useful to predict morbidity in early settings, but is of real
value for surgical audit. The main studies exploring po-
tential predictors for postoperative complications after
surgery for PHC are shown in Table 4.
Most of the patients with PHC present with jaundice at
diagnosis but the impact of bilirubin serum level on post-
operative outcomes remains controversial. Persistent
jaundice is associated with bacterial translocation,
impaired coagulation, renal, or liver dysfunctions.10,27
Some studies showed no impact on postoperative compli-
cations rates,5,11,16,21,23 while others did.10,22,29 In the
present series, preoperative bilirubin serum level had no
significant impact on severe or specific posthepatectomy
complication rates. However, patients with increased bili-
rubin serum levels at the time of liver resection appear to
have a high risk of developing postoperative hemorrhage,
as shown in Table 2.
Routine preoperative biliary drainage of the future liver
remnant was proposed to increase the safety of major liver
resections for PHC.2,3,30 However, some surgical teams
prefer to selectively use biliary drainage,10,16 as was the
case in the present series. Ascending cholangitis is the most
feared complication after biliary drainage; the presence of
cholangitis at the time of liver resection has been associ-
ated with increased morbidity and mortality rates in some
Table 4 Studies from literature exploring risk factors for postoperative complications after major hepatectomies for perihilar
cholangiocarcinoma.
Study Period Patients
resected for
PHC (n)
Major liver
resections ( 4
segments), %
Overall
morbidity, %
Liver
failure, %
Mortality, % Independent risk
factors for
complications
Nagino et al,13 2001
Nagoya, Japan
1990e1999 105 84 81 28 9.5d NA
Sano et al,11 2006
National Cancer
Center Tokyo,
Japan
2000e2004 102 63 50 0 0d Cholangitis for overall
morbidity
Dinant et al,21 2006
Amsterdam
Academic Medical
Center,
Netherlands
1988e2003 99 38 66 10 15c None for overall
morbidity, mortality
Hasegawa et al,22
2007
Kyoto University
Hospital, Japan
1990e2003 44 100 47 16 2c Bilirubin serum level,
extended
hepatectomies for
liver failure
Kennedy et al,24 2009
Memorial Sloan
Kettering Cancer
Center, USA
1997e2007 60 100 53 8 10d Absence of biliary
drainage, future live
remnant volume <
30%, blood
transfusions for liver
insufficiency and
mortality
Sakata et al,25 2009
Niigata University,
Japan
1988e2005 81 79 75 NA 11c Cholangitis for
mortality
Hirano et al,23 2010
Hokkaido
University, Japan
2001e2008 126 57 44 16 3.4c Operative time for
overall complications
Ercolani et al,29 2010
Hospital Sant’
Orsola-Malpighi,
Italy
1989e2007 51 96 51 NA 9.8d Blood transfusions,
operating time for
mortality
Chauhan et al,9 2011
Indiana University,
USA
1998e2008 51 47 69a 8 10c NA
Regimbeau et al,16
2011
Multicentre,
European
2008 39 100 72a 7 7.6d NA
Nuzzo et al,6 2012
Multicentre,
Italian
1992e2007 440 82 48 17 8.6c Blood transfusions,
right hepatectomies
for mortality
Nagino et al,5 2013
Nagoya, Japan
1977e2010 574 97 57 53b 4.7c Cholangitis, liver
function, blood loss
for mortality
Farges et al,10 2013
Multicentre,
European
1997e2008 366 100 69a 5 10.7d Bilirubin serum
levels, right
hepatectomies for
mortality
Furusawa et al,7 2014
Shinshu University,
Japan
1990e2012 144 65 72a 32b 1.4d Blood loss for overall
morbidity
Sugawara et al,27
2013
Nagoya, Japan
2001e2011 587 NA NA 5.7 3.3c Age, body mass index,
positive bile culture,
operative time, blood
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Table 4 (continued )
Study Period Patients
resected for
PHC (n)
Major liver
resections ( 4
segments), %
Overall
morbidity, %
Liver
failure, %
Mortality, % Independent risk
factors for
complications
loss, pancreatico-
duodenectomy for
infectious morbidity
Present series 1996e2012 70 100 63a 29b 10d Neutrophil-to-
lymphocyte ratio for
severe complications
Transfused blood
units number for
clinically relevant
liver failure
Portal vein resection
for liver insufficiency
Creatinine serum
levels for bile leak
NA Z not available.
a Morbidity assessed according to Dindo-Clavien classification.
b Posthepatectomy liver failure according to the ISGLS definition.
c Mortality assessed as in-hospital.
d Mortality assessed at 90 days.
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correlation with postoperative complications, as was the
case in the present study. A recent systematic review
associated biliary drainage with increased morbidity but of
no benefit prior to resection for PHC.31 Furthermore, prior
biliary drainage appears to be associated with increased
mortality for left hepatectomies but decreased mortality
for right hepatectomies.10 However, in some studies biliary
drainage was not associated with increased rates of infec-
tious complications27; synbiotic treatment can reduce in-
fectious morbidity rates.32,33 Absence of biliary drainage in
patients with estimated future liver remnant < 30% was
found as an independent risk factor for liver insufficiency
and mortality.24 Selective use of biliary drainage prior to
resection for PHC appears to be the best approach.34,35
Patients with scheduled right hepatectomies and patients
with an estimated future remnant liver volume of < 30% are
more likely to benefit from preoperative biliary
drainage.10,36 The low biliary drainage rate (21%) repre-
sents one of the particularities in the present series; biliary
drainage was indicated only in patients with cholangitis and
impaired renal function. The safety of major hepatec-
tomies without biliary drainage was previously reported in
some other high-volume centers.34,35 Based on the results
of the present study, a more liberal use of a preoperative
biliary drainage should be considered, particularly in pa-
tients with increased bilirubin (with or without cholangitis)
and long-lasting jaundice.
The extent of liver resection was not identified as a risk
factor for clinically relevant complications in the present
series. Previous studies have shown the same re-
sults,5,11,21,23 while others identified left trisectionectomy
and right hepatectomies as independent risk factors for
mortality after surgery for PHC.6,8e10 Caudate lobectomy
appears to reduce morbidity rates in some studies.29Intraoperative blood loss is a significant predictor for
postoperative mortality or morbidity in some studies,5,8,29
including infectious complications27 while others failed to
demonstrate any correlation.25 In the present study,
intraoperative blood loss does not appear to impact severe
or specific posthepatectomy complications rates; however,
an increased number of transfused blood units were an
independent risk factor for clinically relevant liver failure.
Expertise and technical improvements have reduced the
intraoperative blood loss and the need for blood trans-
fusions after surgery for PHC.7,37 A decreased need for
blood transfusions were associated with low mortality and
morbidity rates.7,37
The impact of portal vein resection during major hepa-
tectomies for PHC is controversial. Thus, most of the
studies did not associate venous resection with increased
mortality or morbidity rates,5,6,9,11,16,23 while others
showed increased postoperative complication rates.21 In
the present series, portal vein resection did not influence
severe or clinically relevant specific posthepatectomy
morbidities rates.
Postoperative liver failure represented the most com-
mon and feared complication after major liver resections
for PHC in most of the studies,2e6,8,10,13 as in the present
series. Furthermore, liver failure is considered the main
cause of death after major hepatectomies for PHC,27 as was
the case in the present series. Data from the literature
identify the bilirubin serum level22,24 and extended hepa-
tectomies13,22,24 as independent risk factors for developing
liver insufficiency, while no correlation was established
with biliary drainage,22 albumin serum level,24 or intra-
operative blood loss.22 However, prior biliary drainage was
identified as an independent risk factor in one study.24 The
same study identified the need for perioperative blood
transfusion but not intraoperative blood loss as an
88 T. Dumitrascu et al.independent risk factor for posthepatectomy liver failure.24
The present study showed that although intraoperative
blood loss was not a risk factor, the number of perioper-
atively transfused blood units was an independent predic-
tor for developing clinically relevant liver failure.
Markers of systemic inflammatory response such as
neutrophil-to-lymphocyte ratio have been largely investi-
gated as prognostic factors for malignancies.38 Our previous
studies showed that a neutrophil-to-lymphocyte ratio has a
significant impact on long-term outcomes in patients with
curative-intent surgery for Klatskin tumors.28 Only a few
studies explored the predictive value of the inflammatory
markers on the development of postoperative
complications.39e42 Thus, increased neutrophil-to-
lymphocyte ratio was previously correlated with the risk of
developing postoperative complications after colorectal
surgery,41 emergency abdominal surgery,42 or breast cancer
surgery.39 A recent study identified increased neutrophil-to-
lymphocyte ratio as an independent risk factor for persis-
tent posthepatectomy liver failure (ISGLS definition) in pa-
tients with liver resection and Child-Pugh Grade A
cirrhosis.40 Neutrophil-to-lymphocyte ratio was an inde-
pendent risk factor for the development of severe compli-
cations after major hepatectomies for PHC in the present
series. Furthermore, patients with increased neutrophil-to-
lymphocyte ratio appear to have a high risk of developing
clinically relevant posthepatectomy liver failure, bile leak,
and hemorrhage, as shown in Table 2. Synbiotics appear to
attenuate the systemic inflammatory response.33 In patients
with perihilar cholangiocarcinoma an increased neutrophil-
to-lymphocyte ratio might be a consequence of the infec-
tious/inflammatory complications related to biliary
obstruction.28 In these patients antibiotics and/or a more
liberal approach to preoperative biliary drainage might be
considered to reduce postoperative morbidity rates.
In conclusion, clinically relevant morbidity rates after
major hepatectomies for PHC are high. Liver failure rep-
resents the main complication and is correlated with the
number of transfused blood units. A patient with increased
bilirubinemia appears to have a high risk of postoperative
hemorrhage. Biliary drainage and portal vein resection do
not appear to have a detrimental effect on morbidities.
Neutrophil-to-lymphocyte ratio is a novel independent
predictor for severe morbidity after major hepatectomies
for PHC and may contribute to better and informed deci-
sion-making.
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